191 related articles for article (PubMed ID: 34937547)
1. Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease.
Hernández Cordero AI; Yang CX; Li X; Milne S; Chen V; Hollander Z; Ng R; Criner GJ; Woodruff PG; Lazarus SC; Connett JE; Han MK; Martinez FJ; Reed RM; Man SFP; Leung JM; Sin DD
Respir Res; 2021 Dec; 22(1):316. PubMed ID: 34937547
[TBL] [Abstract][Full Text] [Related]
2. Relationship of Absolute Telomere Length With Quality of Life, Exacerbations, and Mortality in COPD.
Jin M; Lee EC; Ra SW; Fishbane N; Tam S; Criner GJ; Woodruff PG; Lazarus SC; Albert R; Connett JE; Han MK; Martinez FJ; Aaron SD; Reed RM; Man SFP; Leung JM; Sin DD
Chest; 2018 Aug; 154(2):266-273. PubMed ID: 30017346
[TBL] [Abstract][Full Text] [Related]
3. Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life.
Camac ER; Voelker H; Criner GJ;
Respir Med; 2021 Sep; 186():106526. PubMed ID: 34229290
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.
Ra SW; Sze MA; Lee EC; Tam S; Oh Y; Fishbane N; Criner GJ; Woodruff PG; Lazarus SC; Albert R; Connett JE; Han MK; Martinez FJ; Aaron SD; Reed RM; Man SFP; Sin DD;
Respir Res; 2017 May; 18(1):109. PubMed ID: 28558695
[TBL] [Abstract][Full Text] [Related]
5. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.
Han MK; Tayob N; Murray S; Dransfield MT; Washko G; Scanlon PD; Criner GJ; Casaburi R; Connett J; Lazarus SC; Albert R; Woodruff P; Martinez FJ
Am J Respir Crit Care Med; 2014 Jun; 189(12):1503-8. PubMed ID: 24779680
[TBL] [Abstract][Full Text] [Related]
6. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.
Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM
Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098
[No Abstract] [Full Text] [Related]
7. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
8. The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
Vermeersch K; Gabrovska M; Deslypere G; Demedts IK; Slabbynck H; Aumann J; Ninane V; Verleden GM; Troosters T; Bogaerts K; Brusselle GG; Janssens W
Int J Chron Obstruct Pulmon Dis; 2016; 11():687-96. PubMed ID: 27099485
[TBL] [Abstract][Full Text] [Related]
9. Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis.
Cui Y; Luo L; Li C; Chen P; Chen Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():3813-3829. PubMed ID: 30538443
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation frequency and course of COPD.
Halpin DM; Decramer M; Celli B; Kesten S; Liu D; Tashkin DP
Int J Chron Obstruct Pulmon Dis; 2012; 7():653-61. PubMed ID: 23055714
[TBL] [Abstract][Full Text] [Related]
11. Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease.
Naderi N; Assayag D; Mostafavi-Pour-Manshadi SM; Kaddaha Z; Joubert A; Ouellet I; Drouin I; Li PZ; Bourbeau J
Respir Med; 2018 May; 138():129-136. PubMed ID: 29724384
[TBL] [Abstract][Full Text] [Related]
12. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
Ni H; Htet A; Moe S
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
[TBL] [Abstract][Full Text] [Related]
13. Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD.
Leitao Filho FS; Ra SW; Mattman A; Schellenberg RS; Criner GJ; Woodruff PG; Lazarus SC; Albert R; Connett JE; Han MK; Martinez FJ; Leung JM; Paul Man SF; Aaron SD; Reed RM; Sin DD;
Respir Res; 2018 Feb; 19(1):30. PubMed ID: 29444682
[TBL] [Abstract][Full Text] [Related]
14. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.
Solem CT; Sun SX; Sudharshan L; Macahilig C; Katyal M; Gao X
Int J Chron Obstruct Pulmon Dis; 2013; 8():641-52. PubMed ID: 24376348
[TBL] [Abstract][Full Text] [Related]
15. Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trial.
Vermeersch K; Belmans A; Bogaerts K; Gyselinck I; Cardinaels N; Gabrovska M; Aumann J; Demedts IK; Corhay JL; Marchand E; Slabbynck H; Haenebalcke C; Vermeersch S; Verleden GM; Troosters T; Ninane V; Brusselle GG; Janssens W;
Respir Res; 2019 Oct; 20(1):237. PubMed ID: 31665017
[TBL] [Abstract][Full Text] [Related]
16. Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.
Uzun S; Djamin RS; Kluytmans J; Van't Veer NE; Ermens AA; Pelle AJ; Mulder P; van der Eerden MM; Aerts J
Trials; 2012 Jun; 13():82. PubMed ID: 22682323
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin for prevention of exacerbations of COPD.
Albert RK; Connett J; Bailey WC; Casaburi R; Cooper JA; Criner GJ; Curtis JL; Dransfield MT; Han MK; Lazarus SC; Make B; Marchetti N; Martinez FJ; Madinger NE; McEvoy C; Niewoehner DE; Porsasz J; Price CS; Reilly J; Scanlon PD; Sciurba FC; Scharf SM; Washko GR; Woodruff PG; Anthonisen NR;
N Engl J Med; 2011 Aug; 365(8):689-98. PubMed ID: 21864166
[TBL] [Abstract][Full Text] [Related]
18. Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations.
Djamin RS; Bafadhel M; Uzun S; Russell REK; Ermens AAM; Kerstens R; Aerts JGJV; Pavord ID; van der Eerden MM
Respir Med; 2019; 154():27-33. PubMed ID: 31203097
[TBL] [Abstract][Full Text] [Related]
19. Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations.
Pomares X; Montón C; Espasa M; Casabon J; Monsó E; Gallego M
Int J Chron Obstruct Pulmon Dis; 2011; 6():449-56. PubMed ID: 22003290
[TBL] [Abstract][Full Text] [Related]
20. Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy.
Blasi F; Bonardi D; Aliberti S; Tarsia P; Confalonieri M; Amir O; Carone M; Di Marco F; Centanni S; Guffanti E
Pulm Pharmacol Ther; 2010 Jun; 23(3):200-7. PubMed ID: 20025989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
